The impact of continuous glucose monitoring on low interstitial glucose values and low blood glucose values assessed by point-of-care blood glucose meters: Results of a crossover trial

Journal of Diabetes Science and Technology

Volumn 8, Issue 3, 2014, Pages 516-522

  Hermanns, Norbert ^a,b   Schumann, Beatrix ^b   Kulzer, Bernhard ^a,b   Haak, Thomas ^a,b  

^a FIDAM Forschungsinstitut Diabetes Akademie Bad Mergentheim   (Germany)

^b Diabetes Center Mergentheim   (Germany)

Author keywords

Continuous glucose monitoring; Hypoglycemia; Type 1 diabetes

Indexed keywords

GLUCOSE; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTINUOUS GLUCOSE MONITORING; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTERSTITIAL FLUID; MALE; OUTCOME ASSESSMENT; POINT OF CARE TESTING; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; BLOOD; CHEMICALLY INDUCED; COMPARATIVE STUDY; DEVICES; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; EARLY DIAGNOSIS; EQUIPMENT DESIGN; EXTRACELLULAR FLUID; GERMANY; METABOLISM; MIDDLE AGED; POINT OF CARE SYSTEM; PREDICTIVE VALUE; REPRODUCIBILITY;

ADULT; BIOMARKERS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; EARLY DIAGNOSIS; EQUIPMENT DESIGN; EXTRACELLULAR FLUID; GERMANY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MIDDLE AGED; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS;

EID: 84900802362     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296814524105     Document Type: Article

References (20)

1. Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011;343:d3805.
2. Langendam M, Luijf YM, Hooft L, DeVries JH, Mudde AH, Scholten RJ. Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2012;1:CD008101.
3. Battelino T, Conget I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 2012;55:3155-3162.
4. Tamborlane WV, Beck RW, Bode BW, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359:1464-1476.
5. Garg SK, Kelly WC, Voelmle MK, et al. Continuous home monitoring of glucose: improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes. Diabetes Care. 2007;30:3023-3025. (Pubitemid 350255236)
6. Block CD, Keenoy B, Gaal LV. A review of current evidence with continuous glucose monitoring in patients with diabetes. J Diabetes Sci Technol. 2008;2:718-727.
7. Mauras N, Fox L, Englert K, Beck RW. Continuous glucose monitoring in type 1 diabetes. Endocrine. 2013;43:41-50.
8. Wentholt IM, Vollebregt MA, Hart AA, Hoekstra JB, DeVries JH. Comparison of a needle-type and a microdialysis continuous glucose monitor in type 1 diabetic patients. Diabetes Care. 2005;28:2871-2876. (Pubitemid 43942917)
9. Garg SK, Smith J, Beatson C, Lopez-Baca B, Voelmle M, Gottlieb PA. Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems. Diabetes Technol Ther. 2009;11:65-72.
10. Zijlstra E, Heise T, Nosek L, Heinemann L, Heckermann S. Continuous glucose monitoring: quality of hypoglycaemia detection. Diabetes Obes Metab. 2013;15:130-135.
11. Freckmann G, Pleus S, Link M, Zschornack E, Klotzer HM, Haug C. Performance evaluation of three continuous glucose monitoring systems: comparison of six sensors per subject in parallel. J Diabetes Sci Technol. 2013;7:842-853.
12. ABT Diagnostics: Glukometer 3000. 2014. Available from http://www.abt-diagnostic.de/de/glukometer-techdata.html. Accessed January 14, 2014.
13. Bland M. An Introduction to Medical Statistics. Oxford, UK: Oxford University Press; 2000.
14. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care. 2006;29:44-50. (Pubitemid 44033429)
15. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011;34:795-800.
16. Bergenstal RM, Klonoff DC, Garg SK, et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med. 2013;369:224-232.
17. Phillip M, Battelino T, Atlas E, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med. 2013;368:824-833.
18. Cryer PE. Hypoglycemia: still the limiting factor in the glycemic management of diabetes. Endocr Pract. 2008;14:750-756.
19. Freckmann G, Pleus S, Link M, Zschornack E, Klotzer HM, Haug C. Performance evaluation of three continuous glucose monitoring systems: comparison of six sensors per subject in parallel. J Diabetes Sci Technol. 2013;7:842-853.
20. Pleus S, Schmid C, Link M, et al. Performance evaluation of a continuous glucose monitoring system under conditions similar to daily life. J Diabetes Sci Technol 2013;7:833-841.